| Literature DB >> 33173609 |
Dongyan Pan1,2, Mengqiao Xu3,4,5,6,7, Xin Chang1, Mao Xia8, Yibin Fang9, Yinghua Fu10, Wei Shen1, Yue Wang11,2, Xiaodong Sun3,4,5,6,7.
Abstract
Purpose: To establish a method of laser capture microdissection (LCM) and RNA microsequencing for exploring optic nerve crush (ONC)-related early mRNA alterations in retinal ganglion cell (RGC) layer.Entities:
Keywords: laser capture microdissection; microsequencing; optic nerve crush; retinal ganglion cell layer
Mesh:
Substances:
Year: 2020 PMID: 33173609 PMCID: PMC7594581 DOI: 10.1167/tvst.9.11.30
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Figure 1.Workflow of laser capture microdissection-based sequencing. (A) Workflow of optimizing the LCM protocol. (B) Workflow of the study of early mRNA alterations in RGC layer after ONC. (C) LPC of cells in RGC layer for mRNA sequencing (scale bar: 50 µm). (D) “Cut and LPC” method for RGC layer for RT-PCR (scale bar: 50 µm)
Figure 2.Effect of section thickness and slide type on cell capture success, RNA yield, and integrity after LCM. (A) Effect of section thickness and slide type on cell capture success. Both 20-µm–thick and 30-µm–thick sections mounted on PEN membrane-coated slides led to poor capture success (16% vs. 20%, P > 0.05). Sections mounted on glass slides led to good capture success (both 100%). (B) Effect of section thickness on RNA yield. Twenty-micrometer–thick sections showed a yield of 1.52 ± 0.25 ng/µL, and 30-µm–thick sections showed a yield of 2.29 ± 0.31 ng/µL (P < 0.05).
Figure 3.Analysis of scRNA-seq results. (A) Volcano plot of DEGs between ONC and control samples. Genes with a fold change ≥ 2 and a q value < 0.05 were chosen. A total of 8744 DEGs were included, with 4411 upregulated genes and 4333 downregulated genes. (B) Biomarkers of RGC layer cells. Both RGC markers and glia markers were identified in our sequencing data.
Differentially Expressed Genes With a |log2Ratio|≥10 in RGCs After ONC
| Gene | Log2 Fold Change | Q Value | Up/Down | Gene Name | Full Name |
|---|---|---|---|---|---|
| Gene27639 | 11.70331 | 0 | Up | Atf3 | Activating transcription factor 3 |
| Gene29150 | 11.4495 | 0 | Up | Lgals3 | Lectin, galactoside-binding, soluble, 3 |
| Gene35168 | 11.15631 | 2.35E-172 | Up | LOC102551701 | |
| Gene1274 | 10.90482 | 3.32E-151 | Up | Plaur | Plasminogen activator, urokinase receptor |
| Gene10710 | 10.47381 | 1.28E-120 | Up | Tmem140 | Transmembrane protein 140 |
| Gene22509 | −10.0667 | 2.07E-81 | Down | Maml1 | Mastermind-like 1 |
Figure 4.Verification of candidate genes. (A) RT-PCR of DEGs with a |log2Ratio|≥10. Atf3, Lgals3, LOC102551701, Plaur and Tmem140 levels were found to be upregulated, whereas Maml1 mRNA was found to be decreased at one, two, and three days after crush in the ONC eyes compared to the control eyes. (B) Immunohistochemistry of ATF3 three days after crush. In the control retina, there was low Atf3 immunoreactivity, while in the ONC retina, Atf3 expressed at a high level (green: ATF3; blue: DAPI; scale bar: 200 µm). (C) Immunohistochemistry of Maml1 three days after crush. In control retinas, there was high Maml1 immunoreactivity, while in ONC retinas, Maml1 immunoreactivity was low in the RGC layer (red: Maml1; blue: DAPI; scale bar: 200 µm).